Analyst Ratings for Calliditas Therapeutics (CALT)

CALT Rating Summary

  |   Expand Research on CALT
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/31/2024 Citi Yigal Nochomovitz Downgrade Neutral
(Buy)		 39.00
(30.00)		 37.94
(40.00)		 5.43% Details
5/28/2024 Jefferies Maury Raycroft Downgrade Hold
(Buy)		 39.00
(58.00)		 22.42
(40.00)		 78.41% Details